Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9180170rdf:typepubmed:Citationlld:pubmed
pubmed-article:9180170lifeskim:mentionsumls-concept:C0014644lld:lifeskim
pubmed-article:9180170lifeskim:mentionsumls-concept:C0376526lld:lifeskim
pubmed-article:9180170lifeskim:mentionsumls-concept:C0021051lld:lifeskim
pubmed-article:9180170lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9180170lifeskim:mentionsumls-concept:C2673594lld:lifeskim
pubmed-article:9180170lifeskim:mentionsumls-concept:C0033105lld:lifeskim
pubmed-article:9180170pubmed:issue6lld:pubmed
pubmed-article:9180170pubmed:dateCreated1997-6-27lld:pubmed
pubmed-article:9180170pubmed:abstractTextThe prevalence of Epstein-Barr virus (EBV) and the recently identified Kaposi's sarcoma (KS)-associated herpesvirus (also designated human herpesvirus 8 [HHV-8]) was determined in oral lesions and oral neoplasms common to persons with human immunodeficiency virus (HIV) infection. Oral lesions were examined by polymerase chain reaction (PCR) for EBV and HHV-8 DNA and by Southern blot analysis for EBV clonality. EBV was detected by Southern blot in hairy leukoplakia lesions, in a subset of AIDS-related lymphomas, and in saliva from HIV-positive persons but not in pseudohairy leukoplakia lesions, oral aphthous ulcers, or oral KS lesions. EBV was detected, however, by PCR in most of the lesions, while HHV-8 was detected only in oral KSs. The absence of HHV-8 DNA in both the EBV-associated hairy leukoplakia lesions and in the EBV-associated AIDS-related lymphomas strengthens the etiologic relationship of EBV to these pathologies and the etiologic role of HHV-8 in KS.lld:pubmed
pubmed-article:9180170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9180170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9180170pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9180170pubmed:languageenglld:pubmed
pubmed-article:9180170pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9180170pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9180170pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9180170pubmed:statusMEDLINElld:pubmed
pubmed-article:9180170pubmed:monthJunlld:pubmed
pubmed-article:9180170pubmed:issn0022-1899lld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:EdwardsR HRHlld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:Raab-TraubNNlld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:QuinlivanE...lld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:PattonLLlld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:Webster-Cyria...lld:pubmed
pubmed-article:9180170pubmed:authorpubmed-author:WohlDDlld:pubmed
pubmed-article:9180170pubmed:issnTypePrintlld:pubmed
pubmed-article:9180170pubmed:volume175lld:pubmed
pubmed-article:9180170pubmed:ownerNLMlld:pubmed
pubmed-article:9180170pubmed:authorsCompleteYlld:pubmed
pubmed-article:9180170pubmed:pagination1324-32lld:pubmed
pubmed-article:9180170pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:meshHeadingpubmed-meshheading:9180170-...lld:pubmed
pubmed-article:9180170pubmed:year1997lld:pubmed
pubmed-article:9180170pubmed:articleTitleEpstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions.lld:pubmed
pubmed-article:9180170pubmed:affiliationDepartment of Microbiology and Immunology and Lineberger Cancer Center, University of North Carolina at Chapel Hill, 27599-7295, USA.lld:pubmed
pubmed-article:9180170pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9180170pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed